source
- Moderna launches Phase 3 trial of mRNA bird flu vaccine after US funding cutModerna has begun enrolling participants in a Phase 3 trial of its mRNA-1018 vaccine targeting H5 influenza (bird flu). The trial aims to include about 4,000 healthy adults in the United States and…
- AbbVie allocates $1.4 billion for new 185-acre manufacturing campus in Durham, NCAbbVie has disclosed more details of its $100 billion pledge to the United States, setting aside $1.4 billion to build its first manufacturing campus in North Carolina. The project will cover a 18…